Resources

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. Country decision-makers will need to weigh the value of HPV vaccines against other national health priorities, against other vaccines entering the market, and, for some countries, against expanding coverage of existing vaccines. With these cost and financing obstacles resolved, developing countries would be able to build robust programs to immunize adolescents and thus dramatically reduce the incidence of cervical cancer.

This edition of PATH Today features a main article about the neveripine pouch, "Protecting newborns against HIV," and includes updates on the Meningitis Vaccine Project's plans to introduce a vaccine in Burkina Faso in 2008, PATH's nomination as a Laureate for the Tech Museum Awards, and the organization's recognition as a top social entreprenuer in Fast Company magazine. The issue also includes details about the Gates Partnership Challenge and other opportunities for donors to engage and learn about PATH.

In 2007, UNICEF asked PATH to conduct a field evaluation of three World Health Organization prequalified reuse-prevention feature syringes used for vaccine reconstitution during a measles campaign on Lombok, Indonesia. The evaluation sought to identify the training and introduction requirements of these syringes and establish an understanding of their acceptability, performance, and safety during field use.

This document summarizes the results of a study among children in the Philippines who received both measles and Japanese encephalitis vaccines at nine months of age. Data for this follow-up study were collected one year post-vaccination.

Available on CD-ROM, this interactive tool addresses the Indian regulatory systems for product approval in the areas of drugs, vaccines, biopharmaceuticals, medical devices and diagnostics, and biofortified foods. It compares the Indian and US Food and Drugs approval processes; lists key institutions and individuals in India involved in regulatory approvals; lists organizations, committees, and groups that are part of the regulatory system; and provides a database of referenced extracts of key legislations, forms, and templates. This interactive tool allows users to build and analyze various scenarios of product approval applications. Easy-to-navigate and hyperlinked flowcharts provide indicative timelines for approvals, so users can map the various stages in the approval process.